Atlas Trials

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

Clinical trial NCT03781323 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03781323
Sponsor
University of Rochester
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Rectal Cancer
Start date
2019-05-03
Primary completion
2022-06-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.